TB-500 / Thymosin β4 (preclinical focus) — Thymosin β4 (and the related research peptide TB-500, a synthetic peptide fragment inspired by thymosin β4) appear in a substantial preclinical literature as modulators of tissue repair, cell migration, and angiogenic responses. Animal and cellular studies report roles in cytoskeletal remodeling, reduction of apoptosis and inflammation at injury sites, and enhanced wound closure in diverse models (dermal wounds, ischemic injury, and tendon/heart injury models), with mechanistic analyses implicating actin-sequestering activity, MMP regulation, and paracrine effects on repair-related gene programs. Reviews of thymosin β4 biology place it among endogenous factors released after injury that coordinate complex regenerative cascades in nonclinical systems.

Peptides are available for research purposes only.
Please review and adhere to our Terms and Conditions before ordering.